This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Cambium (CMBM) Q2 Earnings Beat Estimates, Revenues Lag
by Zacks Equity Research
Cambium (CMBM) beats second-quarter earnings estimates despite soft revenues due to sluggishness from service providers.
Coinbase (COIN) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Coinbase's (COIN) Q2 earnings are likely to benefit from increased adoption of a greater number of crypto assets and higher volatility coupled with a rise in interest across the entire crypto-economy.
Universal Display (OLED) Misses on Q2 Earnings and Revenues
by Zacks Equity Research
Universal Display (OLED) misses second-quarter earnings and revenue estimates due to headwinds weighing on consumer spending.
5 Stocks to Buy Ahead of Earnings Results Next Week
by Nalak Das
Five companies are slated to beat earnings estimates next week. These are: TTWO, IONS, CELH, LMND and GO.
Qorvo (QRVO) Q1 Earnings and Revenues Outpace Estimates
by Zacks Equity Research
Qorvo (QRVO) beats fiscal first-quarter earnings and revenue estimates due to strong growth across cellular applications.
ADTRAN (ADTN) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
ADTRAN (ADTN) beats second-quarter earnings estimates on healthy demand trends, end-to-end fiber broadband solutions and improved customer diversification.
Knowles' (KN) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Knowles (KN) beats second-quarter earnings estimates but misses on revenues due to weak demand for MEMS microphones.
Wall Street Analysts Believe Lemonade (LMND) Could Rally 46%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 46.4% upside potential for Lemonade (LMND). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
MetLife (MET) to Announce Q2 Earnings: Here's What to Expect?
by Zacks Equity Research
MetLife's (MET) second-quarter results are likely to reflect increased premiums and improved profits in Latin America.
Lemonade (LMND) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Kemper (KMPR) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Kemper (KMPR) delivered earnings and revenue surprises of -26.53% and 0.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Lemonade (LMND) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Lemonade (LMND) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Unum Group (UNM) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Unum Group (UNM) Q2 results are likely to reflect higher persistency, higher sales and favorable incidence.
What's in the Cards for Prudential (PRU) in Q2 Earnings?
by Zacks Equity Research
Prudential's (PRU) Q2 results are likely to benefit from business growth and favorable underwriting results in both group life and disability, offset by lower net investment spread results and market depreciation.
Will Assurant (AIZ) Pull Off a Surprise This Earnings Season?
by Zacks Equity Research
Assurant's (AIZ) second-quarter results are likely to reflect organic growth from strong U.S. sales, an increase in global mobile devices serviced and continued growth from renters insurance.
How Investors Can Grab Better Returns for Finance Using the Zacks ESP Screener
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Lemonade and MasTec have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Lemonade and MasTec have been highlighted as Zacks Bull and Bear of the Day.
Bull of the Day: Lemonade (LMND)
by Kevin Cook
50-60% revenue growth toward $300 million has analysts raising estimates for this Insur-Tech small cap
Wall Street Analysts Believe Lemonade (LMND) Could Rally 61%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Lemonade (LMND) points to a 60.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Lemonade (LMND) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Lemonade (LMND) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Lemonade (LMND) Q1 Earnings, Revenues Beat, Premiums Up Y/Y
by Zacks Equity Research
Lemonade (LMND) Q1 results reflect gross earned premiums improved, driven by an increase in-force premium earned offset by higher expense.
Lemonade (LMND) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of 15.38% and 2.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Fidelity National (FNF) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Fidelity National (FNF) Q1 earnings are likely to have benefited from higher direct premium, agency premiums as well as escrow, title-related and other fees.
What's in the Cards for Lemonade (LMND) in Q1 Earnings?
by Zacks Equity Research
Lemonade's (LMND) Q1 results are likely to reflect a shift of business mix toward products with higher average policy values, higher customer base and improved premium per customer.
SelectQuote (SLQT) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
SelectQuote (SLQT) delivered earnings and revenue surprises of 78.95% and 5.46%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?